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Introduction: Adult stem cell-derived hepatocytes transplantation holds considerable promise for future clinical
individualized therapy of liver failure or dysfunction. However, the low engraftment of the available hepatocytes in
the liver disease microenvironment has been a major obstacle.
Methods: Acellular human amniotic membrane was developed as a three-dimensional scaffold and combined with
hepatocyte-like cells derived from human adipose stem cells to engineer a hepatic tissue graft that would allow
hepatocyte engraftment in the liver effectively.
Results: The hepatic tissue grafts maintained hepatocyte-specific gene expression and functionality in vitro. When
transplanted into the surgical incision in livers for engraftment, the engineered hepatic grafts significantly
decreased the degree of liver injury caused by a carbon tetrachloride treatment and generated cords that were
similar to the ductal plates in the liver between the acellular human amniotic membrane and the liver of receipts at
day 3 post-transplantation. The hepatic tissue grafts maintained the expression of human hepatocyte-specific
markers albumin, hepatocyte nuclear factor 4α, and cytochrome P450 2B6 in the liver of receipts, and acquired
human-specific drug metabolism ability at eight weeks post-transplantation.
Conclusions: The acellular human amniotic membrane has the ability to maintain the functional phenotype of the
hepatocyte-like cells derived from human adipose stem cells. Functional acellular human amniotic
membrane-hepatocytes grafts integrated with the liver decreases the acute liver injury of mice. These
engineered tissue constructs may support stem cell-based individualized therapy for liver disease and for
bioartificial liver establishment.Introduction
Hepatocyte transplantation, especially using hepatocytes
derived from patient adipose stem cells (ASCs), might be-
come safer and easier than whole organ transplantation to
cure patients suffering from liver-based metabolic diseases
or end-stage liver dysfunction [1–4]. The delivery of these
cells and promotion of their efficient engraftment is a chal-
lenging task [5]. Placing healthy hepatocytes via intrahepa-
tic injection, intrasplenic delivery, or portal vein infusion* Correspondence: culture@ccmu.edu.cn
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altered architectures due to fibrosis and cirrhosis [6]. There-
fore, implantation or extrahepatic transplantation to pro-
vide an additional site of hepatic function represents a new
approach for hepatocyte transplantation [7–9]. New devel-
opments in liver engineering technology have motivated re-
search into the development of functional liver grafts that
could be connected to a recipient’s system [10, 11].
An ideal scaffold with relevant aspects of the hepatic
microarchitecture and extracellular matrix (ECM) com-
ponents plays important roles in hepatocyte adhesion
and differentiation, as well as in promoting tissue mor-
phogenesis, to create implantable liver tissues or grafts
[12–14]. Human amniotic membrane (HAM) has beendistributed under the terms of the Creative Commons Attribution 4.0
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dures and for tissue regeneration because this material is
inexpensive and easily obtained and because its availability
is virtually limitless [15]. Before the material is applied, the
amniotic membrane (AM) donor is required to undergo a
thorough health screening, and the membrane must
undergo an established processing routine, which includes
preservation, sterilization, and de-epithelialization [16].
ECM components of acellular human amniotic membrane
(AHAM), such as collagen type I, collagen type IV, lam-
inin, and fibronectin, which have biological properties
similar to the hepatic ECM, make this membrane a poten-
tially attractive grafting material to facilitate hepatocyte
transfer [17, 18]. Recent findings indicate that HAM may
reduce the severity of liver fibrosis in a bile duct ligation
rat model [19, 20]. However, little is known about the pos-
sibility of AHAM as a scaffold for hepatocyte attachment,
functional maintenance, and transplantation. The aims
of this study were to determine the biocompatibility of
AHAM with human adipose stem cell-derived hepatocyte-
like cells (hASC-HLCs) [21] and to assess the ability of
AHAM to maintain the function of hepatocytes in vitro
and in a hepatic implant in a carbon tetrachloride (CCl4)-
induced acute hepatic injury mouse model in vivo.
Methods
Preparation of the AHAM
HAM was obtained from a cesarean section operation
with informed patient consent and under the approval
of the Ethics Committee of Capital Medical University
(Beijing, China). A maternal donor with no history of
premature membrane rupture, endometritis, or meco-
nium ileus was selected at a prenatal visit approximately
2 weeks before delivery and underwent a series of sero-
logical tests, including screens for HIV-1/2, hepatitis B,
hepatitis C, human T-cell lymphotropic virus type, syph-
ilis, cytomegalovirus, and tuberculosis. Repeat investiga-
tions were performed 6 months after delivery.
To prepare the AHAM, the HAM was peeled from the
placenta, rinsed extensively in sterile phosphate-buffered
saline (PBS) containing 200 U/mL penicillin, 200 ug/mL
streptomycin, and cut into approximately 5 cm× 5 cm
pieces, which were placed in dishes with the amniotic epi-
thelial layer face up. The HAM pieces were incubated in
0.25 % trypsin with 0.38 % ethylenediamine tetraacetic acid
(EDTA; Sigma-Aldrich, St. Louis, MO, USA) for 30 minutes
twice at 37 °C, followed by rinsing in sterile PBS and dehy-
dration in glycerol for 48 hours; the glycerol was changed
every day. Next, the fresh AHAM pieces were stored at
4 °C for up to 2 weeks. For generating cryopreserved
AHAM, the fresh AHAM pieces were placed in dishes with
a 1:1 mixture of glycerol and 0.5 % chondroitin sulfate
(Sigma-Aldrich) in MEM-NEAA (Gibco, Carlsbad, CA,
USA) and stored at –80 °C for several months [16].At 24 hours before examination or cell seeding, the
fresh and cryopreserved AHAMs were rehydrated with
sterile PBS, cut into approximately 1.5 cm × 1.5 cm
pieces, which were placed into 24-well cell culture plates
with the basement membrane face up, and cultured with
MEM-NEAA (Gibco) medium for at least 12 hours.
Cell culture and cell seeding
hASCs were cultured and differentiated to hepatocytes
as described previously [21]. Once the hASC-HLCs were
differentiated, these cells were harvested with 0.05 %
trypsin–0.02 % EDTA solution and resuspended in hep-
atic differentiation medium at a density of 3 × 105/ml.
The primary human hepatocytes (ScienCell Research
Laboratories, Carlsbad, CA, USA) were cultured on
collagen type I-coated six-well plates (3 × 105 cells/well)
with hepatocyte medium (ScienCell Research Laboratories).
The rehydrated cryopreserved AHAM pieces were di-
vided into two groups. In the two-dimensional (2D) group,
the AHAM pieces were spread on culture plates and then
air-dried for 2 hours before seeding the cells; in the three-
dimensional (3D) group, the AHAM pieces were spread
on culture plates and maintained in MEM-NEAA medium
without air-drying before cell seeding. hASC-HLCs were
seeded on 2D-AHAM and 3D-AHAM at a density of 1 ×
105/cm2, with hASC-HLCs plated on collagen type I-
coated 24-well cell culture plates as the control.
Real-time RT-PCR
Real-time RT-PCR was performed as described previ-
ously [21, 22]. Total cellular RNA was extracted from
3 × 105 cells with the RNeasy Mini Kit (QIAGEN,
Hilden, Germany) according to the manufacturer’s
instructions. For PCR analysis, 1 μg RNA was reverse-
transcribed to cDNA using Superscript III reverse tran-
scriptase and random hexamer primers (Invitrogen,
Carlsbad, CA, USA). Real-time PCR analysis was per-
formed on an ABI Prism 7300 Sequence Detection Sys-
tem using the SYBR Green PCR Master Mix (Applied
Biosystems, Foster City, CA, USA). The reaction con-
sisted of 10 μl SYBR Green PCR Master Mix, 1 μl of a
5 μM mix of forward and reverse primers, 8 μl water,
and 1 μl template cDNA in a total volume of 20 μl.
Cycling was performed using the default conditions of
the ABI 7300 SDS Software 1.3.1 (Applied Biosystems).
The relative expression of each gene was normalized
against 18S rRNA. Data are presented as the mean ±
standard deviation (SD). The primers used are presented
in Additional file 1.
Histochemistry and immunofluorescence
The cells or tissue section were fixed with 4 % parafor-
maldehyde for 20 minutes at room temperature,
followed by permeabilization with 0.3 % Triton X-100 in
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20 % goat serum (ZSGB-BIO, Beijing, China) or 1 % gelatin
(Sigma-Aldrich) for 60 minutes at room temperature. The
cells were then incubated with the following antibodies
against human antigens rabbit anti-albumin (ALB) at 1:200
(Sigma-Aldrich), rabbit anti-Cytochrome P450 (CYP) 2B6
at 1:50 (Santa Cruz Biotechnology, Dallas, TX, USA), rabbit
anti-collagen I at 1:100, rabbit anti-fibronectin at 1:200,
mouse anti-collagen IV at 1:100, mouse anti-laminin at
1:200 (ZSGB-BIO), mouse anti-multidrug resistance-
related protein 2 (MRP2) at 1:100 (Santa Cruz), mouse
anti-hepatocyte nuclear factor (HNF) 4α at 1:50 (Santa
Cruz), and mouse anti-human nuclei at 1:1000 (Millipore,
Darmstadt, Germany) or rat monoclonal antibody against
mouse CD31 at 1:50 (Santa Cruz) at 4 °C overnight. A
Vector® M.O.M.™ immunodetection kit (Vector Laborator-
ies, Inc., Burlingame, CA, USA) was used according to the
manufacturer’s protocol to detect the mouse primary
monoclonal antibodies for HNF4α and human nuclei on
mouse tissues after hASC-HLC–3D-AHAM transplant-
ation. Following three 5-minute washes in PBS with
gentle agitation, an Alexa Fluor-conjugated secondary
antibody (1:500; Invitrogen) was added, and the sam-
ples were incubated for 1 hour at 37 °C. The nuclei
were counterstained with 4′,6-diamidino-2-phenylin-
dole (DAPI; Sigma-Aldrich). The stained cells or tissue
sections were examined under a Leica TCS SP8 con-
focal microscope (Leica, Wetzlar, Germany). For de-
tecting the expression of CD31, the tissue sections
were examined with the PV-6004 Polink-1 HRP DAB
detection system and ZLI-9017 DAB Kit (ZSGB-BIO).
The tissue sections were examined under an Axio
Imager A2 microscope (Zeiss, Oberkochen, Germany).Scanning electron microscopy
For scanning electron microscopy (SEM) analysis, the
samples were fixed in 3 % glutaraldehyde in 0.1 M phos-
phate buffer, pH 7.2, for 120 minutes at 4 °C, postfixed
in 1 % osmium tetroxide for 60 minutes at room
temperature, and dehydrated in 50 %, 70 %, 80 %, 90 %,
and 100 % ethanol for 10 minutes, respectively. The
samples were then air dried, mounted, sputter coated
with gold, and examined using a Hitachi S-4800 scan-
ning electron microscope (Hitachi, Tokyo, Japan).Transmission electron microscopy
For the ultra-structural analysis, the differentiated cells
were fixed in 2.5 % glutaraldehyde in 0.1 M phosphate
buffer, pH 7.2, for 120 minutes at 4 °C and postfixed in
1 % osmium tetroxide in 0.1 M phosphate buffer. The
samples were embedded using the Spurr embedding kit,
and sections were examined using a JEM-2100 electron
microscope (JEOL, Tokyo, Japan).ALB analysis
Medium was harvested following 24 hours of culture for
the different cell populations. The ALB content of the
culture supernatants was quantified using a commercially
available enzyme-linked immunosorbent assay (ELISA) kit
(Alpha Diagnostic Intl, San Antonio, TX, USA) according
to the manufacturer’s protocol.
CYP activity assay
Ethoxyresorufin-O-deethylase (EROD), methoxyresorufin-
O-deethylase (MROD), and pentoxyresorufin-O-deethylase
(PROD) assays were performed to determine the activities
of CYP1A1, CYP1A2, and CYP2B as described previously
[21]. The differentiated cells were treated with 1 μM 7-
ethoxyresorufin (Fanbo biochemical, Beijing, China),
methoxyresorufin (Fanbo biochemical), and pentoxyresorufin
(Sigma-Aldrich) for 24 hours, respectively. The fluorescent
products of CYP450 substrates leaked from cells were deter-
mined at a wavelength of 585 nM in the absorption under
Infnite® 200 PRO (Tecan, Männedorf, Switzerland). Quanti-
tative studies employed the high-purity reference standard
of resorufin (Fanbo biochemical) for assay standardization.
Bile canaliculus analysis
The cells were incubated with 10 μM 5(6)-carboxy-2,7-
dichlorofluorescein diacetate (CDFDA; Sigma-Aldrich)
at 37 °C for 10 minutes to allow its internalization and
subsequent translocation into the bile canaliculus (BC)
lumen by MRP2 to determine the BC function. After ex-
tensive washes, the capacity of the BC to contain the
fluorescent CDF was analyzed under a Leica microscope
(Leica) as described previously [21].
Measurement of the plasma amino transferase levels
The plasma alanine amino transferase (ALT) and aspar-
tate aminotransferase (AST) levels were measured using
a Mindray BS-200 analyzer (Mindray, Shenzhen, China).
Acute liver failure induction in mice and hepatic tissue
transplantation
Athymic nude BALB/c male mice aged 6–8 weeks re-
ceived care according to the Capital Medical University
guidelines. All protocols were approved by the Commit-
tee for Animal Care. The mice were injected with a sin-
gle intraperitoneal dose of CCl4 solution in olive oil
(5.0 ml/kg body weight as 1 %, vol/vol; Sigma-Aldrich)
to induce acute liver injury [4]. Vehicle (olive oil)-
injected mice (n = 3) were used as controls.
At 24 hours after CCl4 treatment, hASC-HLCs that
were cultured on 3D-AHAM for 3 days and that con-
tained 1 × 105 cells were implanted at the edge of the su-
perior right lobe of the liver with a 0.5 cm long incision
under isoflurane anesthesia. 3D-AHAM pieces without
cells were used as controls. The mice were sacrificed at
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there are three to six mice for transplantation. The CCl4
treatment was readministered at the end of another
week for the 2-week group, and at the end of every week
for the 8-week group. Serum ALT and AST levels were
determined at the end of the procedure. Histological
analysis of liver tissues was conducted by serial tissue
sectioning and staining with hematoxylin & eosin (H&E),
and the area of injury was assessed using ImageJ software
(National Institutes of Health, Bethesda, MD, USA).
Human nuclei, ALB, and HNF4α, CYP2B6, and mouse-
specific CD31 expression were examined at different
points by immunofluorescence.
Drug metabolism activity assay
The drug metabolism activity was analyzed as described
previously [23]. Ketoprofen (15 mg/kg; Sigma-Aldrich)
was administrated intravenously to the mice post trans-
plantation of the hASC-HLC–3D-AHAM graft or 3D-
AHAM in the injured liver. Urine was collected 2 hours
after administration. Then 100 μl urine was mixed with
100 μl of 0.5 M acetate buffer (pH 5.0), and 10 μl of 1 N
KOH was added to urine samples, incubated at 80 °C for
3 hours, neutralized by 10 μl of 1 N HCl, and then centri-
fuged (15,000 rpm, 4 °C, 5 minutes). The supernatant was
subjected to mass spectrometry (Quattro micro API;
Waters, Milford, MA, USA). The ionspray voltage was –
4500 V and the analyzed m/z transition (Q1/Q3) for keto-
profen, 1-hydroxyketoprofen, and glucuronide-conjugated
ketoprofen was 253.06, 269.35, and 429.34, respectively.
Statistical analysis
At least three independent determinations of each par-
ameter were compared among the treatment groups by
one-way analysis of variance using the statistical soft-
ware SPSS 11.5 (IBM Corporation, Armonk, NY, USA).
Differences were considered significant if p <0.05. All
data are presented as the mean ± SD.
Results
AHAM retained the major components of the AM matrix
Fresh and treated HAM pieces were examined to estab-
lish whether the treatment successfully removed cellular
components and to determine the decellularization
process. The morphology of the AM surface under
phase-contrast microscopy showed that no cells were
visible in the treated (Figure S1B in Additional file 2)
and cryopreserved (Figure S1C in Additional file 2)
HAM pieces compared with the fresh HAM pieces
(Figure S1A in Additional file 2). H&E staining confirmed
that the decellularization process was successful (Figure
S1E, F in Additional file 2), compared with the fresh
HAM pieces (Figure S1D in Additional file 2). SEM
analysis demonstrated that the histoarchitecture of thebasement membrane was maintained and that no obvi-
ous disruption was present following decellularization
and cryopreservation in AHAM (Figure S1H, I in
Additional file 2), while a single layer of amnion epithe-
lial cells were visible in the fresh HAM (Figure S1G in
Additional file 2). Transmission electron microscopy
(TEM) analysis demonstrated that a meshwork of col-
lagenous fibrils and stroma were also preserved in
AHAM (Figure S1J in Additional file 2).
The HAM pieces were then examined for the presence
of major components of the ECM, including collagen
type I, collagen type IV, fibronectin, and laminin, before
and after decellularization and cryopreservation to deter-
mine whether the basement membrane proteins were
retained following decellularization. Immunohistochemi-
cal analysis showed that these four types of components
were all labeled by monoclonal antibodies (Additional
file 3). Collagen type I and fibronectin staining were ob-
served in the basement membrane and in the compact
layer of the AHAM, and the distribution of collagen type
IV and laminin was primarily in the surface of the base-
ment membrane and appeared to be intact in a linear pat-
tern. Therefore, we confirmed that the AHAM retained
the natural architecture and components of the AM matrix
after decellularization with trypsin–EDTA and cryopreser-
vation with glycerol.
AHAM promotes the functional maturation of the
hASC-HLCs
The hASC-HLCs were seeded on collagen type I-coated
cell culture plates and on 2D-AHAM. The morphology
of the hepatocytes was then observed using phase-
contrast microscopy at different time points to assess
the biocompatibility of the AHAM. Within 2 hours after
seeding, most of the cells cultured on collagen type I
had adhered to the substrate and exhibited irregular
shapes; however, the cells cultured on 2D-AHAM
remained round. The cells cultured on 2D-AHAM
began to adhere at approximately 6 hours after seeding
and completely adhered to the AM matrix by 12 hours
after seeding. By 72 hours of culture, the cells on colla-
gen type I exhibited typical hepatocyte morphology with
a polygonal shape; however, the cells on 2D-AHAM ag-
gregated into clusters containing between 2 and 10
round cells (Additional file 4). Using SEM, the cells cul-
tured on collagen type I appeared markedly flattened,
with sharp edges and stiff protrusions (Fig. 1a); however,
the morphology of the cells cultured on 2D-AHAM was
clearly changed, with a smaller size, spheroidal shape,
and abundant villi on the cell surface (Fig. 1b).
Immunofluorescence staining data verified that the
cells on 2D-AHAM had significant staining for MRP2
(Fig. 1d), an apical membrane marker of hepatocytes,
compared with the cells on collagen type I-coated plates
Fig. 1 Properties of hASC-HLCs cultured on collagen type I-coated glass slides and on 2D-AHAM. SEM shows the morphology of hASC-HLCs
cultured on collagen type I-coated glass slides (a) and on 2D-AHAM (b) for 72 hours in vitro. Immunofluorescence staining of human MRP2 of
hASC-HLCs cultured on collagen type I-coated glass slides (c) and on 2D-AHAM (d). Arrow shows the location of the BC. e Real-time RT-PCR was
used to analyze the expression of hepatocyte function-specific genes of hASC-HLCs plated on different substrates. The freshly differentiated
hASC-HLCs (indicate that differentiated cells do not trypsinize and reseed after the end of the differentiated program of 21 days) and human
hepatocytes were used as controls. The relative expression of each gene was normalized to 18S rRNA. *Statistically significant compared with the
hASC-HLCs cultured on collagen type I (p <0.05). f Levels of ALB secreted by the hASC-HLCs cultured on different substrates as analyzed by ELISA.
CYP cytochrome, 2D-AHAM cryopreserved and dried acellular human amniotic membrane, hASC human adipose stem cell, HLC hepatocyte-like cell
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transporters, the cells were cultured with CDFDA, a
compound which is metabolized into a fluorescent
marker, and transported by polarized cells via MRP2
into BC. The results showed that hASC-HLCs also
formed a functional BC structure on the AHAM
(Additional file 5).
Real-time RT-PCR analyses showed that the mRNA
levels of hepatic metabolism functional markers, includ-
ing CYP3A4, CYP7A1, and CYP2B6, in the cells cul-
tured on 2D-AHAM were significantly higher than the
freshly differentiated cells (in situ), cells on collagen type
I, and primary human hepatocytes (Fig. 1e).
The level of ALB secreted by hASC-HLCs cultured on
2D-AHAM was also significantly higher than that pro-
duced by the freshly differentiated cells and the cells on
collagen type I at 72 hours of culture (Fig. 1f). These re-
sults were consistent with the morphological observations,
indicating that the AHAM has good biocompatibility with
hepatocytes and promotes the functional maturation of
hASC-HLCs.
hASC-HLCs reorganized into a hepatic tissue-like structure
on 3D-AHAM
hASC-HLCs were seeded on 3D-AHAM to assess the
behaviors and functions of cells on natural AHAM. The
cells aggregated into clusters on the AHAM at 24 hours
of culture (Fig. 2a), and the cells on the smooth AHAMformed a 3D tissue-like structure by 72 hours of culture
(Fig. 2b). Although the cells on 2D-AHAM also aggre-
gated into small clusters after 72 hours of culture (Figure
S3F in Additional file 4), they seldom organized into a
3D structure and the AHAM seemed to remain smooth
(Fig. 2b insert). Routine histology, immunohistochemical
staining, and TEM were performed to examine this 3D
tissue-like structure. Upon histological analysis, the
hepatocytes appeared well integrated into the AHAM
and formed a net-like structure in the center of the
tissue (Fig. 2c, d). Additionally, the majority of the
cells were ALB-positive (Fig. 2e). The negative control
using isotype IgG for immunofluorescence is shown
in Fig. 2e (insert). TEM analysis confirmed that the
hepatocytes in cultured hepatic tissues contained
abundant mitochondria and that tight junctions and
BC architecture formed between the adjacent hepato-
cytes (Fig. 2f ).
Various hepatocyte characteristics were determined to
investigate whether a 3D hepatic tissue-like culture was
able to maintain the function of hepatocytes. The ex-
pression level of PCK2 gene in the cells cultured on 3D-
AHAM was higher than those of the cells cultured on
2D-AHAM, but lower than the freshly differentiated
cells and primary human hepatocytes. The gene expres-
sion levels of CPS1 and APOC1 in the cells cultured
on 3D-AHAM were significantly higher than those of
the cells cultured on 2D-AHAM and the freshly
Fig. 2 Properties of hASC-HLCs cultured on 3D-AHAM in vitro. Macroscopic appearance of the hASC-HLC–3D-AHAM cultured on day 1 (a) and
day 3 (b) in vitro. Macroscopic appearance of the hASC-HLC–2D-AHAM cultured on day 3 in vitro (b) (insert). H&E staining showed that the
hASC-HLCs attached to the AHAM intensely and formed a 3D nest-like structure (c, d) on day 3. Scale bars: 100 μm (c), 50 μm (d). e Immunofluorescence
staining of ALB of hASC-HLC–3D-AHAM on day 3. The negative control using isotype IgG for immunofluorescence (e) (insert). Scale bar: 50 μm. f TEM
analysis of the ultrastructure of hASC-HLC–3D-AHAM on day 3. Scale bar: 1 μm. AHAM acellular human amniotic membrane, BC bile canaliculus,
Mt mitochondria, N nucleus, rER rough endoplasmic reticulum, TJ tight junction
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tocytes. Interestingly, the gene expression levels of
CYP1A2, CYP2E1, CYP2B6, and CYP3A4 in the cells
cultured on 3D-AHAM were significantly higher than
those of the freshly differentiated cells, the cells cultured
on 2D-AHAM, and primary human hepatocytes. The
gene expression levels of CYP7A1 in the cells cultured
on 3D-AHAM were significantly higher than those of
the freshly differentiated cells and primary human hepa-
tocytes, but there was no difference between the cells
cultured on 2D-AHAM and 3D AHAM (Fig. 3).
ALB secretion, ammonia detoxification, and CYP450
activity were detected at day 3 of culture to evaluate the
functional activity of hASC-HLCs on 2D-AHAM and
3D-AHAM. The ALB level (11 ng/105 cells/day) secreted
by hASC-HLCs cultured on 3D-AHAM was higher than
the level secreted by the freshly differentiated cells, and
the cells on 2D-AHAM at 72 hours of culture (Fig. 4a).Fig. 3 Expression levels of hepatocyte function-specific genes in hASC-HLC
analyze the expression of hepatocyte function-specific genes in hASC-HLCs
respectively) on day 3. The freshly differentiated hASC-HLCs and human he
was normalized to 18S rRNA. ΔStatistically significant compared with the 2D
2D-AHAM and the freshly differentiated hASC-HLCs (p <0.05). **Statistically
hASC-HLCs, and human hepatocytes (p <0.05). #Statistically significant compa
(p <0.05). AHAM acellular human amniotic membrane, APOC1 apolipoprotein
1A2, CYP2B6 cytochrome P450 2B6, CYP2E1 cytochrome P450 2E1, CYP3A4 cyt
stem cell, HLC hepatocyte-like cell, PCK2 phosphoenolpyruvate carboxykinaseSimilarly, the level of urea production in hASC-HLCs
cultured on 3D-AHAM was also higher than that of the
freshly differentiated cells and the cells on 2D-AHAM
(Fig. 4b). The results presented in Fig. 4c indicate that
the activities of CYP1A1 and CYP2B in hASC-HLCs cul-
tured on 3D-AHAM were significantly higher compared
with those in hASC-HLCs cultured on 2D-AHAM and
the freshly differentiated cells. The activities of CYP1A2
in hASC-HLCs cultured on 3D-AHAM were higher than
the freshly differentiated cells, but there was no differ-
ence between the cells cultured on 3D-AHAM and 2D-
AHAM (Fig. 4c).
Taken together, these results suggested that the func-
tion of hASC-HLCs cultured on 3D-AHAM was rela-
tively higher than that of the hASC-HLCs cultured on
the 2D-AHAM. Moreover, the 3D-AHAM culture con-
dition is likely to be more similar to the in vivo condi-
tion than the monolayer culture condition.s plated on 2D-AHAM and 3D-AHAM. Real-time RT-PCR was used to
plated on 2D-AHAM and 3D-AHAM (represented as 2D and 3D,
patocytes were used as controls. The relative expression of each gene
-AHAM (p <0.05). *Statistically significant compared with the
significant compared with the 2D-AHAM, the freshly differentiated
red with the freshly differentiated hASC-HLCs and human hepatocytes
C-I, CPS1 carbamoyl-phosphate synthase 1, CYP1A2 cytochrome P450
ochrome P450 3A4, CYP7A1 cytochrome P450 7A1, hASC human adipose
2
Fig. 4 Functional properties of hASC-HLCs on 3D-AHAM in vitro. a ALB secretion of hASC-HLCs cultured on 2D-AHAM and 3D-AHAM, and freshly
differentiated hASC-HLCs (represented as 1, 2, and 3, respectively) analyzed by ELISA. b Ammonia metabolism, as reflected by urea synthesis, was
determined in the hASC-HLCs cultured on 2D-AHAM and 3D-AHAM, and freshly differentiated hASC-HLCs (represented as 1, 2, and 3, respectively).
c EROD, MROD, and PROD assays for the activities of CYP1A1, CYP1A2, and CYP2B in hASC-HLCs cultured on 2D-AHAM and 3D-AHAM, and freshly
differentiated hASC-HLCs. *Statistically significant compared with the hASC-HLCs cultured on 2D-AHAM and freshly differentiated hASC-HLCs (p <0.05).
#Statistically significant compared with the freshly differentiated hASC-HLCs (p <0.05). AHAM acellular human amniotic membrane, CYP cytochrome,
hASC human adipose stem cell, HLC hepatocyte-like cell
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immunodeficient mice
The hASC-HLC–3D-AHAM constructs were implanted
into an immunodeficient mouse model with CCl4 treat-
ment to test whether the hASC-HLC–3D-AHAM con-
structs can engraft after transplantation. The acute liver
injury induced by a single-dose injection of CCl4 was ev-
idenced by an increase in the plasma ALT level to >2500
U/l (normal range, <50 U/l), by an increase in the
plasma AST level to >2200 U/l (normal range, <80 U/l),
and by larger necrotic areas around the central venous
as determined by histochemistry analysis 24 hours after
CCl4 treatment (Additional file 6).
Acute liver injury was validated by analyzing the massive
necrosis during histological examination and the serum
ALT levels in the injured mice with the hASC-HLC–3D-
AHAM construct or with AHAM only to evaluate the
beneficial effect of the hASC-HLC–3D-AHAM construct
on the recovery of the CCl4-injured liver after implant-
ation. H&E staining (Fig. 5a, b) showed that the areas of
inflammation, sinusoid congestion, and hemorrhage
decreased and that the serum ALT level decreasedsignificantly in mice implanted with hASC-HLC–3D-
AHAM constructs compared with the mice implanted
with AHAM only (Fig. 5c, d). Interestingly, the trans-
planted AHAM only attached the middle of the liver lobes
and did not integrate with the liver tissue (Fig. 5a). In con-
trast, approximately 33 % of the mice (n = 6) displayed in-
tegrated hASC-HLC–3D-AHAM transplants (Fig. 5b).
The results suggested that the hASC-HLC–3D-AHAM
engraftment might alleviate the liver injury induced by
CCl4.
Histological and immunohistochemical analyses were
performed at days 3, 7, and 14 post transplantation to
detect the engraftment of the transplanted hASC-HLC–
3D-AHAM constructs. The results showed that the
hASC-HLC–3D-AHAM constructs had engrafted into
the livers of the mice at day 3 post transplantation
(Fig. 6a). H&E staining showed that the tissue-like con-
structs were restricted to the cut edge of each liver and
that the cells in this construct formed large net-like
structures (Fig. 6b, c). Immunohistochemical analysis
confirmed that the cells in the construct stained positive
for human nuclei, ALB, and HNF4α (Fig. 6d–f ). Data in
Fig. 5 Semiquantitative evaluation of lesions in liver tissue sections following transplantation. H&E staining analysis of the lesions in the liver
tissue at 24 hours after the transplantation of AHAM (a) (n = 3) or hASC-HLC–3D-AHAM grafts (b) (n = 5) in a CCl4-induced liver injury immunodeficient
mouse model. c Percentage of lesion area was evaluated using Image J software. d Plasma levels of ALT were detected. *Statistically significant
compared with the AHAM graft (p <0.05). AHAM acellular human amniotic membrane, ALT alanine amino transferase, HLC hepatocyte-like cell
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AHAM constructs remained integrated into the liver at
days 7 and 14 post transplantation, with large clusters of
hepatocytes arranged into cord-like structures, and the
cells in the construct were also positive for human nu-
clei, ALB, and HNF4α. The results suggested that the
AHAM engraftment of hASC-HLCs in vivo was highly
efficient.
The fate of transplanted hASC-HLC–3D-AHAM
constructs in mice was considered in the long term.
H&E staining showed that the tissue-like constructs
were completely integrated to the liver at day 56 post
transplantation, and the morphology of cells in grafts
near the edge of the host changed to cubic (Fig. 7a).
There was no evidence of abnormal proliferation or re-
gression in the graft. Immunohistochemical analysis
confirmed that the cells in the construct stained posi-
tive for human nuclei (Fig. 7b), and for hepatic func-
tional marker ALB (Fig. 7c), HNF4α (Fig. 7d), and
CYP2B6 (Fig. 7e).
The functional maturation of hASC-HLCs in trans-
plants was evaluated using the drug metabolism activityassay. Mice transplanted with the hASC-HLC–3D-
AHAM constructs or 3D-AHAM were challenged with
ketoprofen, which are known to be metabolized differ-
ently by mice and humans. After the drug exposure, for-
mation of metabolites in urine samples from mouse or
human specific was collected and determined. Results
showed that the 1-hydroxyketoprofen was detected in
mice transplanted with hASC-HLC–3D-AHAM con-
structs or 3D-AHAM. However, the glucuronide-
conjugated ketoprofen was only detected in the urea
sample of mice transplanted with hASC-HLCs at day 56
post transplantation (Additional file 9). Interestingly,
H&E staining showed that the vessel-like structures pre-
sented in the transplanted hASC-HLC–3D-AHAM graft
(Fig. 7a). Immunohistochemical analysis confirmed that
cells composed the vessel-like structures were positive
for mouse CD31 antibody (Fig. 7f ). These results dem-
onstrate that hASC-HLCs maintained the property of
functional maturation, and the potential functional ves-
sels in grafts were connecting with host vessels when
hASC-HLC–3D-AHAM grafts were transplanted in the
long term.
Fig. 6 Implantation of the hASC-HLC–3D-AHAM graft into the CCl4-injured liver. a Gross appearance of the hASC-HLC–3D-AHAM graft in the
injured liver at 3 days post implantation. Arrow shows the location of the graft. b, c H&E staining analysis of the graft integrated with the liver
tissue. Scale bars: 800 μm b, 50 μm c. Immunofluorescence staining of human nuclei (d), ALB (e), and HNF4α (f) in the hASC-HLC–3D-AHAM graft
in the CCl4-injured liver. Scale bar: 50 μm. Negative control using isotype IgG for immunofluorescence (f) (insert). AHAM acellular human
amniotic membrane
Yuan et al. Stem Cell Research & Therapy  (2015) 6:217 Page 10 of 14Our study has demonstrated that hASC-HLC–3D-
AHAM transplantation offers an alternative approach to
the generation of a 3D, transplantable hepatic graft. These
results offered the therapeutic potential using autohepato-
cytes derived from patient stem cells for treating liver
failure.
Discussion
The use of hASC-derived hepatocytes as regenerative
cells in hepatic disease would be advantageous for ethical
and safety reasons, and these autologous cells are immu-
nocompatible, exhibit controlled differentiation, and do
not undergo post-transplantation rejection [3]. Thus far,
the low engraftment of the available hepatocytes has been
a major obstacle [24]. Recently, hepatocytes that have
been assembled on 3D decellularized matrices to generate
liver tissues or patches have become a novel platform for
transplantation [14, 25, 26]. In the present study, we pro-
vide evidence that the AHAM has good biocompatibility
with hepatocytes and promotes the functional maturation
of hASC-HLCs. Moreover, the natural AHAM may induce
the reorganization of hASC-HLCs into a hepatic tissue-
like structure in vitro, which efficiently alleviated the acute
liver injury, was integrated with the liver tissue at theimplantation site, and induced hepatic plate-like structure
in the grafts after transplantation into CCl4-injured livers
of immunodeficient mice.
The AM, which is the innermost layer of the placenta,
is composed of an amniotic epithelial cell layer, a base-
ment membrane, and a thick compact layer or avascular
stroma. The special structure and biological viability of
the amniotic ECM plays a major role in providing
mechanical strength to the amniotic epithelial cells
[18]. Previous evidence showed that the acellular
matrix nature of AM also functions as a primary deter-
minant of attachment, survival, differentiation, and
cytoskeletal organization for epithelial cells of other or-
igins [17], such as pneumocytes [27], limbal epithelial
cells [28, 29], salivary gland cells [30], and dental apical
papilla cells [31]. The AHAM may therefore be a rea-
sonable native scaffold for hepatocyte seeding.
Retaining the biochemical composition and architec-
ture of the matrix in intact AM following the decellulari-
zation process is a critical step for natural scaffold
preparation. First, we demonstrated that the amniotic
epithelial cells were removed completely from the AM
using 0.25 % trypsin and 0.38 % EDTA without any
mechanical scraping [16]. The architecture of the AM
Fig. 7 Long-term properties of the hASC-HLC–3D-AHAM graft in the injured liver following transplantation. a H&E staining analysis of the graft at
8 weeks post implantation. Black arrows show the location of the vessel-like structure. White arrows show the hASC-HLCs with the cubic
morphology. Immunofluorescence staining of human nuclei (b), ALB (c), HNF4α (d), CYP2B6 (e), and mouse CD31 (f) in the hASC-HLC–3D-AHAM
graft in the CCl4-injured liver at 8 weeks post implantation. The control of immunofluorescence using anti-human nuclei was analyzed in tissues
from nontransplanted mice (d) (insert). Black arrows show the location of the vessel-like structure. Dotted lines show the location of the grafts.
Scale bar: 75 μm (b), (c), 100 μm (a), (d). AHAM acellular human amniotic membrane
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basement surface and a meshwork of collagenous fibrils
and stroma, was preserved upon decellularization and
cryopreservation (Additional file 2). Immunostaining
analysis suggested that the matrix of collagen type I, col-
lagen type IV, fibronectin, and laminin found in the hep-
atocyte niche remained relatively intact compared with
that of the fresh AM (Additional file 3). Then, we com-
pared the morphological appearance and function of
hASC-HLCs when seeded on conventional collagen type
I-coated plates and 2D-AHAM configurations. The re-
sults showed that the hASC-HLCs cultured on 2D-
AHAM appeared round or spheroidal, which is the de-
sirable morphology for the functional maintenance of
hepatocytes, versus the flattened and spread polygonal
cells cultured on collagen type I as shown previously
(Fig. 1) [21]. Consistent with these findings, quantitative
gene expression analysis illustrated that hASC-HLCs
cultured on 2D-AHAM exhibited a significant increase
in hepatocyte function-specific gene expression at day 3than the freshly differentiated cells, the cells cultured on
collagen type I, and human hepatocytes (Fig. 1e). An
analogous increase in functional properties, including
CDFDA metabolism and ALB secretion, was observed in
hASC-HLCs cultured on 2D-AHAM (Fig. 1; Additional
file 5). These data demonstrated that the matrix compo-
nents of AHAM have an effect on maintaining the hep-
atocyte phenotype. The accumulated evidence suggested
that both collagen types I and IV, as well as the widely
distributed adhesive protein fibronectin, play an import-
ant role in modulating the formation of hepatocyte po-
larity, such as the organization of cytoskeletal proteins
and the expression of a wide array of liver-specific func-
tions [32]. The AHAM may also be a favorable substrate
for hepatocyte carriers.
Next, we examined whether hASC-HLCs could attach
to the natural AM ECM (3D-AHAM), which not only
preserved the components of the AM matrix but also
retained the specific 3D architecture of the AM matrix.
The results showed that hASC-HLCs self-organized into
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ganizing capacity after 24 hours of culture on 3D-AHAM.
The macroscopically visible clusters continued to form for
up to 72 hours of culture (Fig. 2). We visualized the
formation of homogeneously distributed hASC-HLCs in
this construct as detected by histology, immunostaining,
and TEM. Similarly, the levels of ALB secretion, urea syn-
thesis, and CYP450 enzyme activity were elevated in
hASC-HLCs grown on 3D-AHAM compared with their
counterparts grown on 2D-AHAM and the freshly differ-
entiated cells (Fig. 4). This result suggests that the
3D-AHAM microenvironment or spatial organization
may provide more effective signals, such as the sur-
face texture, variation in pore diameter, spatial pres-
entation of the surface proteins, and mechanical
strength for the hASC-HLCs [32, 33].
The efficiency of the hASC-HLC–3D-AHAM con-
structs for hepatocyte transplantation was further assessed
using a grafting protocol. Our study dramatically demon-
strated that the hASC-HLC–3D-AHAM engraftment alle-
viated the acute liver injury on day 1 and the efficiency
was restricted to the desired target sites on day 3 post
transplantation as determined by histological examination.
The fate of transplanted hASC-HLC–3D-AHAM con-
structs was further examined 2 months post transplant-
ation. Similarly, the constructs were integrated in the liver
of mice as before without multiplying and regressively re-
populating. For assessing progressive humanization or the
functional maturation of hASC-HLCs in host liver, the
ketoprofen metabolism was performed in vivo to validate
the functionality of engrafted cells and the functional ves-
sel formation in transplanted hASC-HLC–3D-AHAM
constructs. Ketoprofen is a propionic acid-class nonsteroi-
dal anti-inflammatory drug with analgesic and antipyretic
effects, which are known to be metabolized differ-
ently by mice and humans [23, 34]. Ketoprofen is
primarily metabolized by CYP450s in mice to form 1-
hydroxyketoprofen, while in humans ketoprofen is
mainly metabolized by UDP-glucuronosyltransferase
to form ketoprofen glucuronide by hydrolysis [35].
We observed that the glucuronide-conjugated keto-
profen was detected in urea in mice transplanted with
hASC-HLC–3D-AHAM using mass spectrometry.
The histological and immunohistochemical analysis
further demonstrated the functional vessel structure
formed in the transplanted hASC-HLC–3D-AHAM
constructs.
Conclusions
The present study suggests that the AHAM has the abil-
ity to maintain the functional phenotype of the hASC-
HLCs and is transplantable. This approach sounds rather
straightforward; alternatives that would aid in providing
surgical potential to manage the bottleneck of donorliver availability for both organ and hepatocyte trans-
plantation are therefore worth discussing. Our findings,
combined with the development of tissue engineering
technologies, may support adult stem cell-based therapy
for future individualized clinical therapy of liver failure
and for bioartificial liver establishment.Additional files
Additional file 1: is Table S1 presenting primers for real-time
RT-PCR. (DOC 35 kb)
Additional file 2: is Figure S1 showing characterization of fresh
HAM and AHAM. The properties of fresh HAM (A, D, G), fresh AHAM
(B, E, H), and cryopreserved AHAM (C, F, I) were determined by phase
microscopy (A, B, C), H&E staining (D, E, F), SEM (G, H, I) and TEM (J). Scale
bars: 50 μm A–F. (TIFF 7208 kb)
Additional file 3: is Figure S2 showing distribution of ECM
components in fresh HAM and in cryopreserved AHAM.
Immunohistological evaluation of fresh HAM and cryopreserved AHAM
before application. Scale bars: 50 μm. HAM human amniotic membrane,
AHAM acellular human amniotic membrane, I collagen type I, IV collagen
type IV, FN fibronectin, LN laminin. (TIFF 9626 kb)
Additional file 4: is Figure S3 showing morphological properties of
hASC-HLCs on different matrices. Morphology of hASC-HLCs cultured
on collagen type I-coated 24-well cell culture plates (A, C, E) and on
cryopreserved 2D-AHAM (B, D, F) was examined by phase microscopy at
6 hours (A, B), 12 hours (C, D) and 72 hours (E, F) after cell seeding. Scale
bars: 50 μm. (TIFF 9815 kb)
Additional file 5: is Figure S4 showing BC analysis. CDFDA is
internalized by hASC-HLCs cultured on collagen type I-coated glass slides
(A) and on 2D-AHAM (B), cleaved by intracellular esterases, and excreted
into the BC as fluorescent CDF. Arrow shows the location of the fluores-
cent CDF. Scale bars: 50 μm. (TIFF 5628 kb)
Additional file 6: is Figure S5 showing acute liver injury in BALB/c
nude mice induced with CCL4. The general appearance of the liver (A)
and H&E staining (B) in BALB/c nude mice that were intraperitoneally
injected with olive oil. Gross appearance of the liver (C) and H&E staining
(D) in BALB/c nude mice that were intraperitoneally injected with CCL4.
At 24 hours post injection, white spots were found at the surface of the
liver (C), and H&E staining (D) showed more numerous and larger
necrotic areas in the liver around the central venous (black arrow). Scale
bar: 100 μm. Plasma levels of ALT (E) and AST (F) were detected in the
CCl4-induced acute liver injury group and in the control. *Statistically
significant compared to the control group (p <0.05). (TIFF 7839 kb)
Additional file 7: is Figure S6 showing properties of the hASC-HLC–
3D-AHAM graft in the injured liver at day 7 following transplantation.
(A) H&E staining analysis of the graft at day 7 post implantation. Scale
bar: 100 μm. Immunofluorescence staining of human nuclei (B), ALB (C),
and HNF4α (D) in the hASC-HLC–3D-AHAM graft in the CCL4-injured liver
at 1 week post implantation. IgG as negative control (B, insert). Scale bar:
50 μm. (TIFF 9840 kb)
Additional file 8: is Figure S7 showing properties of the hASC-HLC–
3D-AHAM graft in the injured liver at day 14 following transplant-
ation. (A) H&E staining analysis of the graft at day 14 post implantation.
Immunofluorescence staining of human nuclei (B), ALB (C), and HNF4α
(D) in the hASC-HLC–3D-AHAM graft in the CCL4-injured liver at 2 weeks
post implantation. IgG as negative control (B, insert). Scale bar: 50 μm.
(TIFF 9846 kb)
Additional file 9: is Figure S8 showing drug metabolism activity of
the hASC-HLC–3D-AHAM graft in the mouse liver at day 56 post
implantation. Ketoprofen (15 mg/kg; Sigma-Aldrich) was administrated
intravenously to the mice post transplantation of the hASC-HLC–3D-
AHAM graft (A, B, C) or 3D-AHAM (D, E, F) in the injured liver. Urine was
collected 2 hours after administration. Then 100 μl urine was mixed with
100 μl of 0.5 M acetate buffer (pH 5.0), and then 10 μl of 1 N KOH was
Yuan et al. Stem Cell Research & Therapy  (2015) 6:217 Page 13 of 14added to urine samples, incubated at 80 °C for 3 hours, neutralized by
10 μl of 1 N HCl, and then centrifuged (15,000 rpm, 4 °C, 5 minutes). The
supernatant was subjected to mass spectrometry (Quattro micro API;
Waters). The ionspray voltage was –4500 V and analyzed m/z transition
(Q1/Q3) for ketoprofen,1-hydroxyketoprofen, glucuronide-conjugated
ketoprofen was 253.06, 269.35, and 429.34, respectively. (B) Amplification
of part 1, (C) amplification of part 2, (E) amplification of part 3, (F)
amplification of part 4. Arrow shows the location of the ketoprofen,
1-hydroxyketoprofen, glucuronide-conjugated ketoprofen, OH-ketoprofen:
1-hydroxyketoprofen; G-ketoprofen: glucuronide-conjugated ketoprofen.
(TIFF 9829 kb)
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